Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor,RunX1T1in ovarian cancer

Aberrant Transforming Growth Factor β1 Signaling and SMAD4 Nuclear Translocation Confer Epigenetic Repression of ADAM19 in Ovarian Cancer

(2015) Michael W.Y. Chan et al.   NEOPLASIA

TGF-β: friend or foe? The role of TGF-β/SMAD signaling in epigenetic silencing of ovarian cancer and its implication in epigenetic therapy

(2010) Jian-Liang Chou et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer

(2010) Jian-Liang Chou et al.   LABORATORY INVESTIGATION

An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules

(2009) Huaxia Qin et al.   BMC Systems Biology

Minireview: Epigenetic Changes in Ovarian Cancer

(2009) Curt Balch et al.   ENDOCRINOLOGY

Multivalent Binding of the ETO Corepressor to E Proteins Facilitates Dual Repression Controls Targeting Chromatin and the Basal Transcription Machinery

(2009) C. Guo et al.   MOLECULAR AND CELLULAR BIOLOGY

Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors

(2008) S. Zhang et al.   CANCER RESEARCH

Transforming Growth Factor-  Regulates Mammary Carcinoma Cell Survival and Interaction with the Adjacent Microenvironment

(2008) B. Bierie et al.   CANCER RESEARCH

Roles of TGF-β family signaling in stem cell renewal and differentiation

(2008) Tetsuro Watabe et al.   CELL RESEARCH

Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers

(2008) N. Dumont et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Progenitor/stem cells give rise to liver cancer due to aberrant TGF-  and IL-6 signaling

(2008) Y. Tang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA